Aerovate Therapeutics (AVTE) Insider Trading & Ownership $9.47 -0.04 (-0.42%) As of 07/18/2025 Add Compare Share Share Insider Trades Stock AnalysisChartCompetitorsDividendEarningsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrendsBuy This Stock Aerovate Therapeutics (NASDAQ:AVTE) Insider Buying and Selling ActivityCurrentInsider OwnershipPercentage24.90%Number OfInsiders Buying(Last 3 Years)0Number OfInsiders Selling(Last 3 Years)9Amount OfInsider Selling(Last 3 Years)$10.47M Get AVTE Insider Trade Alerts Want to know when executives and insiders are buying or selling Aerovate Therapeutics stock? Sign up for InsiderTrades.com's daily newsletter to get the latest insider transactions delivered to your inbox daily. Email Address AVTE Insider Buying and Selling by Quarter Aerovate Therapeutics Insider and Congressional Trades History Insiders and Members of Congress Insiders Only Members of Congress Only Transaction Type Custom Range 1 Month 3 Months 6 Months Year-to-Date 1 Year 2 Years 3 Years Time Frame Start Date End Date Export to Excel Transaction DateNameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionDetails6/14/2024George A EldridgeInsiderSell428$876.05$374,949.40 5/17/2024Hunter GilliesInsiderSell114$737.80$84,109.20 5/16/2024Timothy P. NoyesCEOSell285$755.30$215,260.50 5/2/2024Marinus VerwijsInsiderSell56$735.70$41,199.20 5/1/2024Timothy P. NoyesCEOSell324$711.90$230,655.60 4/17/2024Benjamin T DakeInsiderSell195$782.95$152,675.25 4/16/2024Timothy P. NoyesCEOSell285$864.50$246,382.50 4/10/2024George A EldridgeInsiderSell214$939.75$201,106.50 4/9/2024David S GrayzelDirectorSell339$985.25$333,999.75 4/1/2024Benjamin T DakeInsiderSell95$1,118.95$106,300.25 Get Insider Trades Delivered To Your InboxEnter your email address below to receive a concise daily summary of insider buying activity, insider selling activity and changes in hedge fund holdings. 4/1/2024Timothy P. NoyesCEOSell285$1,050.00$299,250.00 3/27/2024Benjamin T DakeInsiderSell316$978.95$309,348.20 3/25/2024Benjamin T DakeInsiderSell98$980.35$96,074.30 3/19/2024Marinus VerwijsinsiderSell151$912.80$137,832.80 3/13/2024George A EldridgeInsiderSell57$875.70$49,914.90 3/11/2024George A EldridgeInsiderSell98$883.75$86,607.50 3/8/2024George A EldridgeInsiderSell3$875.00$2,625.00 2/23/2024Hunter GilliesInsiderSell14$682.50$9,555.00 2/20/2024Hunter GilliesInsiderSell99$708.05$70,096.95 2/5/2024Ralph NivenInsiderSell131$610.75$80,008.25 1/17/2024Hunter GilliesInsiderSell114$682.50$77,805.00 1/5/2024Ralph NivenInsiderSell131$670.60$87,848.60 12/27/2023Hunter GilliesInsiderSell3$857.50$2,572.50 12/20/2023Hunter GilliesInsiderSell114$682.50$77,805.00 12/13/2023Hunter GilliesInsiderSell60$682.50$40,950.00 12/5/2023Ralph NivenInsiderSell131$570.50$74,735.50 11/27/2023Benjamin T DakeInsiderSell357$568.40$202,918.80 11/24/2023Benjamin T DakeInsiderSell142$550.90$78,227.80 11/22/2023Benjamin T DakeInsiderSell268$530.95$142,294.60 11/1/2023Marinus VerwijsCTOSell27$366.10$9,884.70 11/1/2023Timothy P. NoyesCEOSell31$364.70$11,305.70 9/6/2023Benjamin T DakeInsiderSell112$527.10$59,035.20 8/7/2023Benjamin T DakeInsiderSell293$543.20$159,157.60 7/28/2023Timothy P. NoyesCEOSell156$630.00$98,280.00 7/17/2023Timothy P. NoyesCEOSell129$633.85$81,766.65 7/6/2023Benjamin T DakeInsiderSell293$583.10$170,848.30 7/3/2023Timothy P. NoyesCEOSell285$630.00$179,550.00 6/5/2023Ralph NivenInsiderSell64$569.10$36,422.40 5/19/2023Hunter GilliesInsiderSell1$682.50$682.50 5/17/2023Hunter GilliesInsiderSell31$685.65$21,255.15 Altucher: Turn $900 into $108,000 in just 12 months? (Ad)Bitcoin is breaking out — and one state just created a Strategic Crypto Reserve. James Altucher says this marks the beginning of “Trump’s Great Gain,” a new crypto bull phase driven by emerging federal policies. He believes certain altcoins could turn $900 into $108,000 — and reveals everything in a new presentation.See Altucher’s Great Gain gameplan here5/8/2023Benjamin T DakeInsiderSell293$763.00$223,559.00 5/5/2023Ralph NivenInsiderSell64$730.45$46,748.80 5/3/2023Marinus VerwijsSVPSell21$727.65$15,280.65 5/1/2023Timothy P NoyesCEOSell428$721.35$308,737.80 4/21/2023Hunter GilliesInsiderSell114$682.50$77,805.00 4/6/2023Benjamin T. DakeinsiderSell293$635.95$186,333.35 4/3/2023Timothy P. NoyesCEOSell428$678.65$290,462.20 3/6/2023Benjamin T. DakeinsiderSell293$830.55$243,351.15 3/1/2023Timothy P. NoyesCEOSell428$833.35$356,673.80 2/6/2023Benjamin T. DakeinsiderSell293$860.65$252,170.45 2/1/2023Timothy P. NoyesCEOSell428$793.80$339,746.40 1/6/2023Benjamin T. DakeinsiderSell293$909.30$266,424.90 1/3/2023Timothy P. NoyesCEOSell428$947.45$405,508.60 12/12/2022George A EldridgeInsiderSell285$1,051.40$299,649.00 12/8/2022George A EldridgeInsiderSell343$835.45$286,559.35 12/5/2022Ralph NivenInsiderSell64$608.30$38,931.20 12/1/2022Timothy P. NoyesCEOSell428$630.00$269,640.00 11/30/2022George A EldridgeInsiderSell2$667.10$1,334.20 11/23/2022George A EldridgeInsiderSell36$667.45$24,028.20 11/21/2022George A EldridgeInsiderSell0$665.00$0.00 11/18/2022George A EldridgeInsiderSell24$683.20$16,396.80 11/11/2022Benjamin T. DakeinsiderSell177$724.15$128,174.55 11/8/2022Benjamin T. DakeinsiderSell239$633.15$151,322.85 11/2/2022Marinus VerwijsSVPSell32$661.15$21,156.80 11/1/2022Timothy P. NoyesCEOSell29$682.50$19,792.50 10/17/2022Benjamin T. DakeinsiderSell119$705.60$83,966.40 10/14/2022Benjamin T. DakeinsiderSell3$701.75$2,105.25 10/10/2022Benjamin T. DakeinsiderSell141$591.15$83,352.15 10/7/2022Benjamin T. DakeinsiderSell300$560.35$168,105.00 10/5/2022Ralph NivenInsiderSell64$551.25$35,280.00 9/12/2022Benjamin T. DakeinsiderSell214$606.55$129,801.70 9/8/2022Benjamin T. DakeinsiderSell89$637.00$56,693.00 9/6/2022Benjamin T. DakeinsiderSell261$648.55$169,271.55 8/18/2022Ralph NivenInsiderSell64$741.30$47,443.20 8/16/2022Benjamin T. DakeinsiderSell600$805.00$483,000.00 8/11/2022Benjamin T. DakeinsiderSell38$837.55$31,826.90 8/8/2022Benjamin T. DakeinsiderSell198$861.70$170,616.60 (Data available from 1/1/2013 forward) AVTE Insider Trading Activity - Frequently Asked Questions Who is on Aerovate Therapeutics' Insider Roster? The list of insiders at Aerovate Therapeutics includes Benjamin T Dake, David S Grayzel, George A Eldridge, Hunter Gillies, Marinus Verwijs, Ralph Niven, Timothy P Noyes. Learn more on insiders at AVTE. What percentage of Aerovate Therapeutics stock is owned by insiders? 24.90% of Aerovate Therapeutics stock is owned by insiders. Learn more on AVTE's insider holdings. Which Aerovate Therapeutics insiders have been selling company stock? The following insiders have sold AVTE shares in the last 24 months: Benjamin T Dake ($1,306,032.00), David S Grayzel ($333,999.75), George A Eldridge ($715,203.30), Hunter Gillies ($362,893.65), Marinus Verwijs ($188,916.70), Ralph Niven ($242,592.35), and Timothy P. Noyes ($1,101,134.30). How much insider selling is happening at Aerovate Therapeutics? Insiders have sold a total of 5,526 Aerovate Therapeutics shares in the last 24 months for a total of $4,250,772.05 sold. Aerovate Therapeutics Key ExecutivesMr. Timothy P. Noyes M.B.A. (Age 62)CEO & Director Compensation: $936.9kMr. George A. Eldridge (Age 61)CFO & Treasurer Compensation: $658.6kMr. Timothy J. Pigot (Age 53)Chief Commercial Officer Compensation: $584.6kDr. Benjamin T. Dake Ph.D. (Age 48)Founder, President, COO & Secretary Compensation: $435.5kDr. Marinus Verwijs Ph.D. (Age 48)Chief Technical Officer Compensation: $439.88kDr. Ralph W. Niven M.B.A. (Age 64)M.R, Ph.D., Pharm.S, Chief Scientific Officer Compensation: $372.33kMr. Hunter Gillies M.D. (Age 58)Chief Medical Officer Compensation: $512.74kMs. Donna DeaHead of Regulatory AffairsMs. Susan FischerExecutive Vice President of Development OperationsMr. Stephen K. YuSenior Vice President of Quality More Insider Trading Tools from MarketBeat Related Companies Enliven Therapeutics Insider Trading Structure Therapeutics Insider Trading Cidara Therapeutics Insider Trading Ardelyx Insider Trading Praxis Precision Medicines Insider Trading ProKidney Insider Trading Collegium Pharmaceutical Insider Trading Akebia Therapeutics Insider Trading Amphastar Pharmaceuticals Insider Trading Arcus Biosciences Insider Trading Insider Tracking Tools CEO Purchases/Sales CFO Purchases/Sales Top Insider Buying Stocks Top Insider Selling Stocks Insider Trades Screener Insider Trades Newsletter Congressional Stock Trades Insider Trading By Country U.S. Insider Trading Activity Canadian Insider Trading Activity U.K. Insider Trading Activity Australia Insider Trading Activity Latest Articles 3 Catalysts Driving Plug Power’s Turnaround CaseInsider Selling Hits Market Leaders—Should You Be Worried?Insiders Spent Millions on These 3 Stocks Over the Past 2 Months3 Small Caps Drawing Insider and Institutional SupportDo They Know Something? Insiders & Congress Buy UnitedHealth This page (NASDAQ:AVTE) was last updated on 7/20/2025 by MarketBeat.com Staff From Our PartnersCongress Is Talking Crypto. Here’s What It Means for You …Congress is deep into “Crypto Week” — with new bills that could finally bring clarity to digital assets. Cr...Weiss Ratings | SponsoredTurn $1K into $50K with This DeFi GemTHREE pro-crypto bills just passed the House! Now, experts believe altcoin season is officially here. Crypto 101 Media | SponsoredGenesis 14:13-17 [HIDDEN MEANING?]A mysterious Bible verse from Genesis may hold the key to unlocking what one expert calls an “American birthri...Paradigm Press | SponsoredBuffett to put 90% of his money in this one stock?CPA and CFA says you have WAY too many stocks - just buy these 3 After years working at the biggest accoun...Altimetry | SponsoredThis Could Be the Most Profitable Season of Your LifeInstitutional money is pouring in. Bitcoin ETFs are live. Altcoin adoption is accelerating. This is the sam...Crypto Swap Profits | SponsoredBitcoin just humbled Jeff BezosBitcoin just passed Amazon in total market cap — but most investors are missing the bigger opportunity. Whi...Brownstone Research | SponsoredINVESTOR ALERT: Tiny “$3 AI Wonder Stock” on the Verge of Blasting OffRight now, we’re witnessing a monumental shift in the world.Traders Agency | SponsoredCritical AI announcement set to ignite AI 2.0 I just put together an urgent new presentation that you need to see right away. In short: I believe we are...Timothy Sykes | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Aerovate Therapeutics, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Aerovate Therapeutics With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Free AVTE Stock Alerts